Attached files
| file | filename |
|---|---|
| EX-99.1 - BIOMIMETIC THERAPEUTICS, INC. | v176836_ex99-1.htm |
| EX-99.2 - BIOMIMETIC THERAPEUTICS, INC. | v176836_ex99-2.htm |
| EX-99.4 - BIOMIMETIC THERAPEUTICS, INC. | v176836_ex99-4.htm |
| EX-99.3 - BIOMIMETIC THERAPEUTICS, INC. | v176836_ex99-3.htm |
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported): March 10, 2010 (March 9,
2010)
BIOMIMETIC
THERAPEUTICS, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-51934
|
62-1786244
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
389 Nichol Mill Lane,
Franklin, Tennessee 37067
(Address
of principal executive offices)
(615)
844-1280
(Registrant's
telephone number, including area code)
Not
Applicable
(Former
name, former address and former fiscal year,
if
changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
8.01. Other Events
On March
9, 2010, BioMimetic Therapeutics, Inc. issued a press release that announced
pre-clinical data it presented at the 2010 Orthopedic Research Society (ORS)
meeting in New Orleans this week. A copy of the press release, the
slides presentation and two posters presented at the meeting are furnished as
Exhibit 99.1, Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4 respectively to this
Current Report on Form 8-K.
Item
9.01. Financial Statements and Exhibits
(d) Exhibits
99.1 Press
Release dated March 9, 2010.
99.2 Slide
Presentation
99.3 Poster
– Normal and Diseased Primary Human Tenocytes Proliferate in Response to
rhPDGF-BB
99.4 Poster
– Rotator Cuff Repair in an Ovine Model
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
| BIOMIMETIC THERAPEUTICS, INC. | |||
|
|
By:
|
/s/ Earl Douglas | |
| Name: | Earl Douglas | ||
| Title: | General Counsel | ||
Date: March
10, 2010